<DOC>
	<DOCNO>NCT02276235</DOCNO>
	<brief_summary>The aim double-blind , randomize , placebo-controlled trial evaluate therapeutic effect acupoint stimulation catgut embed complexion , quality life , lipid profile , inflammatory marker , obesity-related hormone peptide obese woman .</brief_summary>
	<brief_title>The Therapeutic Effect Catgut Embedding Obesity</brief_title>
	<detailed_description>We recruit 90 female age 16 year-old 65 year-old body mass index ( BMI ) 27㎞/㎡ waist circumference≧80cm . After inform consent , randomly assign two group . In group A , catgut embed apply six acupuncture point abdomen include Qihai ( Ren-6 ) , Shuifen ( REN-9 ) , bilateral shuidao ( ST-28 ) Siman ( ST-26 ) , prove effective obesity previous study , week six time . In group B , sham catgut embed apply acupoints week six week . This trial go six week six course treatment . Our primary outcome measurement complexion include body mass index ( BMI ) , waist circumstance , waist-hip ratio . In second outcome measurments , evaluate life quality patient use 12-Item Short Form Health Survey ( SF-12 ) develop Medical Outcomes Study ( MOS ) also use questionnaire quality life designate World Health Organization . We also classify patient questionnaire design TCM syndrome obesity . We check blood test include lipid profile ( TG , Chol , HDL-C , LDL-C ) , inflammatory marker , hormone peptide relate obesity insulin , leptin , ghrelin , adiponectin . Each enrol patient evaluated baseline treatment 6 time treatment complete parameter find therapeutic effect mechanism catgut embed acupoints obese woman .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<criteria>body mass index ( BMI ) ≥ 27 kg/m2 waist circumference ( WC ) ≥ 80 cm willing participate fill questionnaires trial . Endocrine disease ( Thyroid disease , pituitary disease , diabetes mellitus ) Autoimmune disease（SLE、SSS、RA） Heart disease ( Heart failure , arrhythmia etc.） Abnormal liver function（GOT &gt; 80U/L、GPT &gt; 80U/L） Abnormal kidney function（serum creatinine &gt; 2.5 mg/dL） Stroke disease past one year Under breast feeding pregnancy Coagulation disorder Subjects keloid disorder Accept weight reduction treatment last two month</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>catgut embed</keyword>
	<keyword>obese woman</keyword>
	<keyword>obesity-related hormone</keyword>
</DOC>